Free Trial

XOMA (XOMAP) Competitors

XOMA logo
$25.69 -0.18 (-0.70%)
As of 07/25/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

XOMAP vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ARAV, ACABW, BFRIW, BTMDW, and BCTXW

Should you be buying XOMA stock or one of its competitors? The main competitors of XOMA include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry.

XOMA vs. Its Competitors

180 Life Sciences (NASDAQ:ATNFW) and XOMA (NASDAQ:XOMAP) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, media sentiment, earnings, valuation, risk and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
180 Life SciencesN/AN/AN/AN/AN/A
XOMA$13.05MN/AN/AN/AN/A

In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.89 equaled XOMA'saverage media sentiment score.

Company Overall Sentiment
180 Life Sciences Very Positive
XOMA Very Positive

Company Net Margins Return on Equity Return on Assets
180 Life SciencesN/A N/A N/A
XOMA N/A N/A N/A

Summary

XOMA beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks.

Get XOMA News Delivered to You Automatically

Sign up to receive the latest news and ratings for XOMAP and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XOMAP vs. The Competition

MetricXOMABiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$136.97M$5.74B$9.54B
Dividend Yield9.29%3.74%4.71%4.02%
P/E RatioN/A3.7828.4120.06
Price / SalesN/A4,478.16443.6492.77
Price / CashN/A13.1936.1858.54
Price / BookN/A42.328.655.87
Net IncomeN/A-$90.99M$3.25B$258.89M
7 Day Performance0.39%4.87%4.31%3.75%
1 Month Performance-0.46%9.02%11.60%12.29%
1 Year Performance0.72%193.24%35.38%17.86%

XOMA Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XOMAP
XOMA
N/A$25.69
-0.7%
N/A+0.7%$0.00$13.05M0.0010Positive News
ATNFW
180 Life Sciences
N/A$0.01
-9.5%
N/A+21.0%$0.00N/A0.007Gap Down
LBPSW
4D pharma
N/AN/AN/AN/A$0.00$522K0.00N/A
AEHAW
Aesther Healthcare Acquisition
N/A$0.00
flat
N/AN/A$0.00N/A0.002
AIMDW
Ainos
N/A$0.16
-2.0%
N/A+95.0%$0.00$106.21K0.0040Gap Up
ALVOW
Alvotech
N/A$1.75
-10.7%
N/A+2.7%$0.00$585.60M0.004Gap Down
ARAV
ARAVIVE
N/A$0.04
flat
N/AN/A$0.00$9.14M0.0020High Trading Volume
ACABW
Atlantic Coastal Acquisition Corp. II
N/A$0.02
flat
N/A-37.0%$0.00N/A0.0015
BFRIW
Biofrontera
N/A$0.10
-2.8%
N/AN/A$0.00$38.00M0.0070Gap Down
BTMDW
biote
N/A$0.01
-1.5%
N/A-97.6%$0.00$199.38M0.00N/AGap Down
BCTXW
BriaCell Therapeutics
N/A$0.06
+15.1%
N/A-79.9%$0.00N/A0.008

Related Companies and Tools


This page (NASDAQ:XOMAP) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners